SCHEMBL5361

SCHEMBL5361

C[CH]OC(CC)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6179279 0.79
SCHEMBL27556864 0.78
SCHEMBL5336 0.76
SCHEMBL2779955 0.76
SCHEMBL2327755 0.76
SCHEMBL6178030 0.75 CA1 (0.32)
SCHEMBL26030 0.75
Propene SCHEMBL28781551 0.74
SCHEMBL6179890 0.74 SMPD1 (0.38)
SCHEMBL10952582 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024040169-A2 METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS THE UNIVERSITY OF CHICAGO (US) 2024-02-22 WO disclosed
CN-109923711-B Binder composition for lithium battery 富士胶片和光纯药株式会社 2023-06-27 CN disclosed
CN-109937500-B Binder composition for lithium battery electrode and electrode using same 富士胶片和光纯药株式会社 2023-04-11 CN disclosed
CN-108770357-B Polymer conjugate vaccines 芝加哥大学 2022-10-28 CN disclosed
EP-3579313-B1 USE OF A BINDER AGENT COMPOSITION FOR LITHIUM BATTERY, SLURRY COMPOSITION FOR LITHIUM BATTERIES COMPRISING THE BINDER COMPOSITION, AND ELECTRODE USING THE BINDER COMPOSITION FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2022-07-27 EP disclosed
CN-114206355-A Methods and compositions for treating cancer with cancer-targeting adjuvants 芝加哥大学 2022-03-18 CN disclosed
US-11258066-B2 Binder agent composition for lithium battery FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2022-02-22 US disclosed
EP-3590940-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2021-06-09 EP disclosed
US-10913745-B2 Octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors HOFFMANN-LA ROCHE INC. (US) 2021-02-09 US disclosed
US-20210015792-A1 OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL HOFFMANN-LA ROCHE INC. (US) 2021-01-21 US disclosed
US-20120041013-A1 NEW AZACYCLIC COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2012-02-16 US disclosed
US-20110092512-A1 NEW HSL INHIBITORS USEFUL IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 US disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
EP-1329160-A2 4-ACYLAMINOPYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-07-23 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed
US-5569309-A TURQUOISE COLOR; MIXTURE OF MONOAZO AND ANTHRAQUINONE DYES DYSTAR JAPAN LTD. (JP) 1996-10-29 US disclosed
EP-0684290-A2 Disperse dye compositions DyStar Japan Ltd. (JP) 1995-11-29 EP disclosed